Tech Stocks Struggle as Wall Street Anticipates Fed Minutes
January 8, 2025 - 18:15
Top technology stocks are facing challenges as they seek to recover from a difficult trading day. Notable names like Nvidia, Palantir, and AMD are striving for gains after experiencing declines. The quantum computing sector is also under pressure, with companies such as Rigetti and IonQ showing significant losses this morning.
As the market navigates these fluctuations, all eyes are on the Federal Reserve, which is scheduled to release the minutes from its most recent interest rate meeting at 2 p.m. ET today. Investors are keen to glean insights that could influence future monetary policy and market dynamics.
In addition to tech stocks, other trending tickers include Moderna, Aurora Innovation, and Exxon Mobil, reflecting a diverse interest across sectors. The day will also feature key guest appearances, starting with Stephanie Roth, Chief Economist at Wolfe Research, followed by industry leaders such as Ken Mahoney, CEO of Mahoney Asset Management, and Cristiano Amon, CEO of Qualcomm. Nela Richardson, Chief Economist at ADP, will also provide insights later in the morning.
MORE NEWS
June 7, 2026 - 04:43
Why Pay More for Gold? GLDM Offers the Same Bullion for a Fraction of GLD's CostA 58-year-old investor with $100,000 parked in SPDR Gold Trust (GLD) as a crisis hedge is paying roughly $300 more per year than necessary for the exact same bars of bullion. That is the...
June 6, 2026 - 00:01
The Spill: Why Financial Pros Are Piling Into IWM Right NowAfter years of playing second fiddle to mega-cap tech stocks, small-cap equities are suddenly the center of attention. The iShares Russell 2000 ETF, known by its ticker IWM, is seeing a wave of...
June 5, 2026 - 04:07
Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified NomineesMedallion Financial Corp. has issued a sharp rebuttal against ZimCal`s latest proxy fight, accusing the investment firm of running a campaign built on distortions and misaligned incentives. The...
June 4, 2026 - 04:31
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the...